Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-41.65%EBITDA Margin
VS
Market
Sector
Industry
History
$ 7.9Close
$ 3.84 - $ 22.77 52-Week Range
Ticker Information
Ticker
MYGNCompany Name
MYRIAD GENETICS INCSector
HealthcareIndustry
Diagnostics & ResearchExchange
NASDAQMYRIAD GENETICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
MYGN - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -346.9M | -41.65% | $ 832.9M |
| 3/31/2025 | $ -53.9M | -6.48% | $ 831.3M |
| 12/31/2024 | $ -50M | -5.97% | $ 837.6M |
| 9/30/2024 | $ -42.7M | -5.18% | $ 823.6M |
| 6/30/2024 | $ -83.5M | -10.41% | $ 802.2M |
| 3/31/2024 | $ -163.7M | -21.14% | $ 774.2M |
| 12/31/2023 | $ -186.1M | -24.71% | $ 753.2M |
| 9/30/2023 | $ -206.9M | -28.17% | $ 734.4M |
| 6/30/2023 | $ -191M | -27.33% | $ 698.9M |
| 3/31/2023 | $ -93.4M | -13.44% | $ 694.7M |
Key Performance Insights, Last 5 Years
- MYRIAD GENETICS INC's latest trailing twelve months (TTM) EBITDA % stands at -26.61%.
- Over the past 5 years, MYRIAD GENETICS INC's average EBITDA % has been -13.87%.
- The median EBITDA % for MYRIAD GENETICS INC during this period was -10.58%
- MYRIAD GENETICS INC reached its highest EBITDA % over the past 5 years at 5.92%.
- The lowest EBITDA % recorded by MYRIAD GENETICS INC in the same timeframe -41.65%
MYRIAD GENETICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for MYRIAD GENETICS INC is calculated as follows: EBITDA [ $ -159M ] / Revenues [ $ 597.5M ]
(=) EBITDA % [ -26.61% ] MYGN - EBITDA Margin, Last 5 years
-41.65%
Minimum
Jun 30, 2025
5.92%
Maximum
Mar 31, 2022
-13.87%
Average
-10.58%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.16% with a standard deviation of 26.84%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.98% |
| max | 97.73% |
| average | 16.16% |
| median | 14.74% |
| std | 26.84% |